Skip to content

Author

G. S. M. Nunes

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Ictus-to-door time as a predictor of delirium in patients with acute ischemic stroke: a prospective cohort study

Background: Delirium is a common and reversible neuropsychiatric complication that follows acute ischemic stroke (AIS). Despite the crescent understanding about your relation with AIS, the role of ictus-to-door time remains unclear in the generation of delirium. Objective: To analyze the correlation between the interva...

Davi Chaves Rocha de Souza, Marcos Paulo Rodrigues de Oliveira, Pedro Henrique Ferreira Sandes et al. · 0 citations
Open access Oct 2026

Is prolonged delirium associated with worse functional outcomes after stroke?

Background: Although the occurrence of delirium is known to negatively impact clinical outcomes, the influence of its duration on long-term functional recovery after stroke remains unclear. Objective: To evaluate the association between prolonged delirium and functional outcome in patients with stroke. Methods: This pr...

Marcos Paulo Rodrigues de Oliveira, Davi Chaves Rocha de Souza, Gabriel Teles de Oliveira Piñeiro et al. · 0 citations
Open access Oct 2026

Glucose-to-platelet ratio: a potential predictor of short-term functional outcome in patients with acute ischemic stroke

Background: Glucose and platelets are two important indicators that are readily available in the emergency setting. The glucose-to-platelet (G/P) ratio appears to be important for hemorrhagic transformation in patients with acute ischemic stroke (AIS). However, its role in functional outcome remains unclear. Objective:...

Gabriel Teles de Oliveira Piñeiro, Davi Chaves Rocha de Souza, Marcos Paulo Rodrigues de Oliveira et al. · 0 citations
Review Open access Oct 2026

Tavapadon as treatment for Parkinson’s disease: a systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials

Background: Current Parkinson’s disease therapies are often limited by adverse events from D2/D3 receptor activation. Tavapadon, a novel selective D1/D5 partial agonist, emerges as a promising alternative for effective motor control with an improved safety profile. Objective: To perform a systematic review, meta-analys...

João Victor Teixeira Costa, S. Baran, João Pedro Fernandes Gonçalves et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.